Literature DB >> 10898071

Anxiety and depression in a community-based rheumatoid arthritis population.

M K Söderlin1, M Hakala, P Nieminen.   

Abstract

OBJECTIVE: To assess anxiety and depression and their explanatory factors in rheumatoid arthritis (RA) in a community-based population.
METHODS: The subscales of the Arthritis Impact Measurement Scales (AIMS) for anxiety and depression were used, and the Health Assessment Questionnaire (HAQ) was used for the assessment of disability. Cross-tabulation and multivariate logistic regression analysis were used to evaluate which variables best describe the patients with either high or low depression and anxiety scores.
RESULTS: Nearly 20% of our patients had probable depression (AIMS depression subscale score > or =4), a figure comparable to earlier hospital-based series. Most of the AIMS anxiety subscale variability was explained by poor physical function and the male sex, while the AIMS depression subscale variability was mostly explained by poor physical function, comorbidities, and social inactivity.
CONCLUSION: In our cross-sectional, community-based RA series, depression was equal to the figures previously reported from hospital-based series. Poor physical function was a powerful explanatory factor of both depression and anxiety.

Entities:  

Mesh:

Year:  2000        PMID: 10898071     DOI: 10.1080/030097400750002067

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  12 in total

1.  Depression and anxiety in rheumatoid arthritis: the role of perceived social support.

Authors:  Y Zyrianova; B D Kelly; C Gallagher; C McCarthy; M G Molloy; J Sheehan; T G Dinan
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

Review 2.  Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways.

Authors:  John A Sturgeon; Patrick H Finan; Alex J Zautra
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

3.  Psychosocial problems among newly diagnosed rheumatoid arthritis patients.

Authors:  C Gåfvels; M Hägerström; B Nordmark; P E Wändell
Journal:  Clin Rheumatol       Date:  2011-11-18       Impact factor: 2.980

4.  Prevalence of irritable bowel syndrome and depression in fibromyalgia.

Authors:  Jayde E Kurland; Walter J Coyle; Anne Winkler; Elizabeth Zable
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

5.  Associates of physical function and pain in patients with patellofemoral pain syndrome.

Authors:  Sara R Piva; G Kelley Fitzgerald; James J Irrgang; Julie M Fritz; Stephen Wisniewski; Gerald T McGinty; John D Childs; Manuel A Domenech; Scott Jones; Anthony Delitto
Journal:  Arch Phys Med Rehabil       Date:  2009-02       Impact factor: 3.966

6.  The impact of disability on depression among individuals with COPD.

Authors:  Patricia P Katz; Laura J Julian; Theodore A Omachi; Steven E Gregorich; Mark D Eisner; Edward H Yelin; Paul D Blanc
Journal:  Chest       Date:  2009-11-20       Impact factor: 9.410

7.  Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis.

Authors:  Sigrid Odegård; Arnstein Finset; Petter Mowinckel; Tore K Kvien; Till Uhlig
Journal:  Ann Rheum Dis       Date:  2007-03-28       Impact factor: 19.103

8.  Effects of Conventional and Biological Drugs Used for the Treatment of Rheumatoid Arthritis on the Quality of Life and Depression.

Authors:  Yakup Ilker Yayikci; Ahmet Karadag
Journal:  Eurasian J Med       Date:  2018-11-30

9.  Associations of Arthritis-Attributable Interference with Routine Life Activities: A Modifiable Source of Compromised Quality-of-Life.

Authors:  K A Theis; T J Brady; C G Helmick; L B Murphy; K E Barbour
Journal:  ACR Open Rheumatol       Date:  2019-08-06

10.  Developing Fine-Grained Actigraphies for Rheumatoid Arthritis Patients from a Single Accelerometer Using Machine Learning.

Authors:  Javier Andreu-Perez; Luis Garcia-Gancedo; Jonathan McKinnell; Anniek Van der Drift; Adam Powell; Valentin Hamy; Thomas Keller; Guang-Zhong Yang
Journal:  Sensors (Basel)       Date:  2017-09-14       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.